Sutro Biopharma Inc (STRO)
2.51
-0.02
(-0.79%)
USD |
NASDAQ |
Nov 22, 16:00
2.52
+0.01
(+0.40%)
After-Hours: 20:00
Sutro Biopharma Price to Book Value: 1.861 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 22, 2024 | 1.861 |
November 21, 2024 | 1.876 |
November 20, 2024 | 1.980 |
November 19, 2024 | 2.002 |
November 18, 2024 | 2.039 |
November 15, 2024 | 2.143 |
November 14, 2024 | 2.558 |
November 13, 2024 | 2.936 |
November 12, 2024 | 3.025 |
November 11, 2024 | 3.262 |
November 08, 2024 | 3.247 |
November 07, 2024 | 3.084 |
November 06, 2024 | 3.067 |
November 05, 2024 | 2.845 |
November 04, 2024 | 2.734 |
November 01, 2024 | 2.63 |
October 31, 2024 | 2.408 |
October 30, 2024 | 2.637 |
October 29, 2024 | 2.63 |
October 28, 2024 | 2.652 |
October 25, 2024 | 2.556 |
October 24, 2024 | 2.563 |
October 23, 2024 | 2.593 |
October 22, 2024 | 2.615 |
October 21, 2024 | 2.697 |
Date | Value |
---|---|
October 18, 2024 | 2.763 |
October 17, 2024 | 2.748 |
October 16, 2024 | 2.793 |
October 15, 2024 | 2.837 |
October 14, 2024 | 2.837 |
October 11, 2024 | 2.808 |
October 10, 2024 | 2.452 |
October 09, 2024 | 2.563 |
October 08, 2024 | 2.608 |
October 07, 2024 | 2.63 |
October 04, 2024 | 2.674 |
October 03, 2024 | 2.615 |
October 02, 2024 | 2.600 |
October 01, 2024 | 2.593 |
September 30, 2024 | 2.563 |
September 27, 2024 | 1.885 |
September 26, 2024 | 1.874 |
September 25, 2024 | 1.788 |
September 24, 2024 | 1.831 |
September 23, 2024 | 1.934 |
September 20, 2024 | 2.031 |
September 19, 2024 | 2.111 |
September 18, 2024 | 2.128 |
September 17, 2024 | 2.160 |
September 16, 2024 | 1.993 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7263
Minimum
Jun 16 2022
4.48
Maximum
Dec 17 2020
2.240
Average
1.997
Median
Price to Book Value Benchmarks
Fulcrum Therapeutics Inc | 0.6813 |
NovaBay Pharmaceuticals Inc | 3.121 |
Palatin Technologies Inc | -- |
iBio Inc | 1.360 |
Theriva Biologics Inc | 0.1446 |
Price to Book Value Related Metrics
PS Ratio | 1.114 |
Price | 2.51 |
Earnings Yield | -64.14% |
Market Cap | 206.97M |